Science Explorer Interactive view Map
Company · San Francisco · United States

Nurix (United States)

nurixtx.comROR OpenAlex
Research works
43
▲ 1008% vs 2013–17
Citations
627
14.6 per fractional work
Top-10% rate
19.5%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Nurix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.26× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 13.64× its world share, 3 worksImmunology and Micro…Chemistry: 1.26× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringMathematics: 0.80× its world share, 0 worksMathematicsPhysics and Astronomy: 0.36× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.80× its world share, 12 worksMedicineDecision Sciences: 0.05× its world share, 0 worksDecision SciencesPsychology: 0.04× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.6×. Every wedge is a field page.

Who are the top researchers at Nurix (United States)?

Ranked on the composite score, Aileen Kelly lead among researchers whose main affiliation is Nurix (United States).

  1. 1 Aileen Kelly United States · #164,569 worldwide 60 citations · 26 works
All ranked researchers at Nurix (United States)

Which keywords describe research at Nurix (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Cancer Immunotherapy, Lymphoma, Therapeutic Targets, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Rituximab5▲ 141×2 topics
  2. Cancer Immunotherapy4▲ 130×3 topics
  3. Lymphoma4▲ 109×2 topics
  4. Therapeutic Targets4▲ 115×4 topics
  5. Prognostic Factors4▲ 39×3 topics
  6. Chronic Lymphocytic Leukemia4▲ 356×1 topic
  7. Genomic Aberrations4▲ 356×1 topic
  8. Immunotherapy3▲ 18×3 topics
  9. CAR T Cells3▲ 170×1 topic
  10. Chimeric Antigen Receptor3▲ 170×1 topic
  11. BET Bromodomains2▲ 340×1 topic
  12. PROTACs2▲ 340×1 topic
  13. Cancer Therapy1▲ 10×5 topics
  14. Dendritic Cells1▲ 66×1 topic
  15. Immunity1▲ 15×1 topic
  16. Tumor Microenvironment1▲ 14×4 topics
  17. PET Imaging1▲ 33×2 topics
  18. Classification1▲ 11×1 topic
  19. Epidemiology1▲ 1.28×4 topics
  20. Immune Checkpoint Blockade1▲ 45×1 topic
  21. Molecular Profiling1▲ 52×1 topic
  22. NK Cell Recognition1▲ 80×1 topic
  23. Natural Killer Cells1▲ 80×1 topic
  24. PD-1 and PD-L11▲ 45×1 topic

Which research topics does Nurix (United States) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Protein Degradation and Inhibitors and Immunotherapy and Immune Responses.

Chronic Lymphocytic Leuk…4Chronic Lymphocytic Leukemia Research: 4 fractional worksCAR-T cell therapy research: 3 fractional worksProtein Degradation and Inhibitors: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksBiochemical and Molecular Research: 1 fractional worksMachine Learning in Bioinformatics: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional works
GeneticsOncologyMolecular BiologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 4 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 Protein Degradation and Inhibitors Molecular Biology 2 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Immune Cell Function and Interaction Immunology 1 works
  8. 8 Biochemical and Molecular Research Molecular Biology 1 works
  9. 9 Machine Learning in Bioinformatics Molecular Biology 0 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.4%not open47.6%

World: 28% of research is openly available.

with international co-authors16.0%domestic only84.0%

World: 19% is written across borders.

How has Nurix (United States)'s research output changed?

Output in 2018–2022 was 1008% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.